An overview of the new medicines approved by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) between April and November 2022. See the 2021 data here and the full PMDA approval archive here.
Hecho conVisme Infographic Maker
written on 18.01.2023
Japan PMDA Drug Approvals 2022
Similar Facts and Figures
Top 10 Pharma Companies in Japan
Below we highlight the top 10 pharma companies in Japan based on data for 2019 sales of ethical drugs in USD billions. Japanese firms Takeda and Daiichi Sankyo came out…
Japan / PMDA Drug Approvals 2021
An overview of the new medicines approved by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) between April and November 2021. See the 2020 data here and the full PMDA approval…
Japan Facts & Figures Snapshot
Number of consultations for drugs in Japan by category in 2016. Oncology drugs leads the way, followed by gastrointestinal drugs and respiratory tract drugs. The launch of new medicines for…
Japan New Drug Approvals 2019
A comprehensive list of the new drugs approved by Japan’s Pharmaceutical and Medical Devices Agency (PMDA) in 2019. Made with Visme Infographic Maker
Japanese PMDA Regenerative Medicine Approvals
A full list of the regenerative medicine products that have been approved by the PMDA, Japan’s drug regulatory body. Made with Visme Infographic Maker
Japan / PMDA New Drug Approvals 2020
Following on from our recent compilations of 2020 new drug approvals in the USA, China, and Switzerland, see below for the Japanese PMDA’s new drug approvals list for April-October 2020.…
Japan / Pharma R&D: In Need of an Upgrade
MSD KK’s Fumitaka Noji, writing in the January 2023 edition of DIA’s Global Forum magazine, outlines some of the key upgrades that Japan’s innovation ecosystem needs to become globally competitive…
Japan / New Emergency Regulatory Approval System: A Rapid Response Mechanism for Future Pandemics
Pfizer’s Kaneko Miyuki, writing in the September 2022 edition of DIA’s Global Forum magazine, shines a light on Japan’s new emergency approval system for pharmaceuticals. Enacted in the wake of…
Asia-Pacific/ Real-World Evidence Regulatory Landscape in Asia Pacific
Writing in the June edition of DIA’s Global Forum magazine, Ellen Sem, Fengyun (Vicky) Han and Annetta C. Beauregard from Janssen Pharmaceutical Companies of Johnson & Johnson, outline the real-world data…